EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis

Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.578
https://www.valueinhealthjournal.com/article/S1098-3015(24)00693-4/fulltext
Title : EE279 Cost-Effectiveness Analysis of Biosimilars and Novel Biologics for Patients With Moderate-to-Severe Psoriasis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00693-4&doi=10.1016/j.jval.2024.03.578
First page :
Section Title :
Open access? : No
Section Order : 10052
Categories :
Tags :
Regions :
ViH Article Tags :